General MedicationsORALGeneric

ABACAVIR SULFATE

Standard Dose

60 MG

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: None (Tentative Approval)

Summary

Approval overview ABACAVIR SULFATE is listed in Drugs@FDA under application 200733 (NDA).

Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient ABACAVIR SULFATE Form and strength TABLET; ORAL - 60 MG Sponsor MATRIX LABS LTD Submission history Latest submission status date: 2010-11-29 00:00:00.

Structured Monograph

Clinical summary

Approval overview ABACAVIR SULFATE is listed in Drugs@FDA under application 200733 (NDA). Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient ABACAVIR SULFATE Form and strength TABLET; ORAL - 60 MG Sponsor MATRIX LABS LTD Submission history Latest submission status date: 2010-11-29 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: None (Tentative Approval)
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.